...
首页> 外文期刊>ACS medicinal chemistry letters >Development and Biological Evaluation of a Photoactivatable Small Molecule Microtubule-Targeting Agent
【24h】

Development and Biological Evaluation of a Photoactivatable Small Molecule Microtubule-Targeting Agent

机译:光活化小分子微管靶向剂的开发和生物学评价

获取原文
获取原文并翻译 | 示例

摘要

Photoremovable protecting groups added to bioactive molecules provide spatial and temporal control of the biological effects. We present synthesis and characterization of the first photoactivatable small-molecule tubulin inhibitor. By blocking the pharmacophoric OH group on compound 1 with photoremovable 4,5-dimethoxy-2-nitrobenzyl moiety we developed the photocaged prodrug 2 that had no effect in biological assays. Short UV light exposure of the derivative 2 or UV-irradiation of cells treated with 2 resulted in fast and potent inhibition of tubulin polymerization, attenuation of cell viability, and apoptotic cell death, implicating release of the parent active compound. This study validates for the first time the photoactivatable prodrug concept in the field of small molecule tubulin inhibitors. The caged derivative 2 represents a novel tool in antitubulin approaches.]]>
机译:<![cdata [ src =] http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/amclct/2017/amclct.2017.8.issue-4/acsmedchemlett.6b00483/20170407/19/20170407/19/20170407/19/20170407/19/20170407/图像/介质/ ML-2016-00483N_0008.gif“>添加到生物活性分子中的光环保护基团提供了对生物效应的空间和时间控制。我们呈现了第一光活化小分子微管蛋白抑制剂的合成和表征。通过用光放大的4,5-二甲氧基-2-硝基苄基部分封闭化合物对化合物 1 / B>上的药物OH基团,我们开发了在生物测定中没有作用的复印前药B> 2。用衍生物的短紫外线暴露于用 2(2)处理的细胞或UV照射导致对小管蛋白聚合,细胞活力的衰减和凋亡细胞死亡的快速和有效的抑制作用,暗示母体活性化合物的释放。本研究首次验证了小分子小管蛋白抑制剂领域的光活化前药概念。笼养衍生物 2 代表抗胰岛素方法的新型工具。]]]>

著录项

  • 来源
    《ACS medicinal chemistry letters》 |2017年第4期|共6页
  • 作者单位

    School of Medical Sciences and Charles Perkins Centre The University of Sydney Sydney NSW 2006 Australia;

    School of Medical Sciences and Charles Perkins Centre The University of Sydney Sydney NSW 2006 Australia;

    School of Medical Sciences and Charles Perkins Centre The University of Sydney Sydney NSW 2006 Australia;

    QIMR Berghofer Medical Research Institute 300 Herston Road Herston QLD 4006 Australia;

    QIMR Berghofer Medical Research Institute 300 Herston Road Herston QLD 4006 Australia;

    Oncogenic Signalling Laboratory and Brain Cancer Discovery Collaborative Centre for Cancer Research Hudson Institute of Medical Research 27-31 Wright Street Clayton VIC 3168 Australia;

    Institute of Pharmacy Christian-Albrechts-University of Kiel Gutenbergstra?e 76 24118 Kiel Germany;

    Institute of Pharmacy Christian-Albrechts-University of Kiel Gutenbergstra?e 76 24118 Kiel Germany;

    School of Medical Sciences and Charles Perkins Centre The University of Sydney Sydney NSW 2006 Australia;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;化学;
  • 关键词

    glioblastoma; Photoactivatable caged prodrug; tubulin inhibitor;

    机译:胶质母细胞瘤;可光活泼的笼子前药;管蛋白抑制剂;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号